- Investing Ideas
- U.S. Pharmaceuticals & Biotech High Risk Large Caps
U.S. Pharmaceuticals & Biotech High Risk Large Caps
Results
5
Are you holding one of these? A list of some of the most volatile large-cap stocks over the past five years.
5 companies
Natera
Market Cap: US$28.2b
A diagnostics company, engages in the development and commercialization of molecular testing services worldwide.
NTRA
US$196.61
7D
-3.2%
1Y
36.1%
BioNTech
Market Cap: US$20.1b
A biotechnology company, develops and commercializes immunotherapies to treat cancer and infectious diseases in Germany.
BNTX
US$90.84
7D
-12.5%
1Y
-9.4%
Illumina
Market Cap: US$18.7b
Provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa.
ILMN
US$121.50
7D
-5.8%
1Y
44.3%
Regencell Bioscience Holdings
Market Cap: US$12.1b
Operates as a Traditional Chinese medicine (TCM) bioscience company in Hong Kong.
RGC
US$23.66
7D
-7.0%
1Y
21,306.7%
Elanco Animal Health
Market Cap: US$11.8b
An animal health company, innovates, develops, manufactures, and markets products for pets and farm animals worldwide.
ELAN
US$23.45
7D
-4.1%
1Y
125.7%